Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
about
Nanoparticle ligand presentation for targeting solid tumorsPhosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalizationA novel pretargeting method for measuring antibody internalization in tumor cells.Agonist-biased trafficking of somatostatin receptor 2A in enteric neuronsSelective targeting of melanoma using N-(2-diethylaminoethyl) 4-[18F]fluoroethoxy benzamide (4-[18F]FEBZA): a novel PET imaging probe.Imaging and therapy of hSSTR2-transfected tumors using radiolabeled somatostatin analogs.Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method.[Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma.Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.Receptor-mediated internalization is critical for the inhibition of the expression of growth hormone by somatostatin in the pituitary cell line AtT-20.Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signaling.Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization.Somatostatin receptor expression in multiple endocrine neoplasia and in von Hippel-Lindau disease.Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells.
P2860
Q27009522-3076C358-9FDE-42C7-8E57-12F9B20358F0Q28248809-692E7665-A889-4766-BB7B-1EB84A5EAC83Q35942571-944FDE99-4E37-4C5D-A04D-BF70347630A4Q37150973-C5ADD18E-B404-43F3-82EB-BC7566D8FC8AQ38695346-010924E6-8E60-4891-802C-7BC8B38CADA1Q39162740-574EEDBF-29F2-4C8C-90D0-51410ABB4EE9Q39590527-367A4FA1-594A-4188-AFB5-D38911FE2B35Q39606627-C9554809-C945-4702-BAEF-A76BD0903C64Q40648014-2990999F-FCDB-4D06-BEAB-90847454B036Q40945781-494CFA27-0F21-403C-8EE5-06E8C91534D6Q41568422-C4861801-ADE7-40CC-8A88-92C7353B3686Q42484756-D484DCCF-FFCC-466A-AF5E-72ECE3842DC4Q47723794-95B1DBC7-9B71-4746-AEBC-7497241E7E1BQ47775608-A7A1C14F-DB1C-4E33-ADC3-0C366E05E695Q52868783-8322DA38-1D2B-422F-92B2-D3434DD490E4
P2860
Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Internalization of the radioio ...... rease by unlabeled octreotide.
@en
Internalization of the radioio ...... rease by unlabeled octreotide.
@nl
type
label
Internalization of the radioio ...... rease by unlabeled octreotide.
@en
Internalization of the radioio ...... rease by unlabeled octreotide.
@nl
prefLabel
Internalization of the radioio ...... rease by unlabeled octreotide.
@en
Internalization of the radioio ...... rease by unlabeled octreotide.
@nl
P2093
P356
P1433
P1476
Internalization of the radioio ...... rease by unlabeled octreotide.
@en
P2093
Breeman WA
Hofland LJ
Lamberts SW
Waaijers M
Zuyderwijk J
van Koetsveld PM
P304
P356
10.1210/EN.136.9.3698
P407
P577
1995-09-01T00:00:00Z